Table 8.
Positive CEA level | Low KPS |
Extracranial Metastases | Multiple BM | Age | Location of CRC | Others | Score | |
---|---|---|---|---|---|---|---|---|
Thurmaier et al. (2020) | Liver | |||||||
Quan et al. (2020) | x | x | x | x | ||||
Mo et al. (2020) | x | x | x | x | x | |||
Boysen et al. (2020) | N2 | |||||||
Jin et al. (2020) * | x | x | ||||||
Rades et al. (2020) | x | |||||||
Muzaffar et al. (2019) * | x | |||||||
Lu et al. (2019) | x | x | ||||||
Imaizumi et al. (2019) | x | x | History of chemotherapy | |||||
Quan et al. (2019) | x | x | ||||||
Taylor et al. (2019) * | Liver | |||||||
Kim B. et al. (2018) * | x | |||||||
Roussile et al. (2018) | Lung | x | PDL1+ | |||||
Duan et al. (2018) | Bone | x | x | |||||
Yang L. et al. (2018) | x | x | Pathology | |||||
Del Carpio Huerta et al. (2018) | x | x | ||||||
Berghoff et al. (2017) * | x | |||||||
Sun et al. (2016) * | x | x | ||||||
Nieder et al. (2016) | x | |||||||
Roussile et al. (2016) * | x | |||||||
Karivedu et al. (2015) * | x | x | ||||||
Gu et al. (2015) | x | x | ||||||
Chang et al. (2015) * | x | KRAS mutation | ||||||
Berghoff et al. (2013) * | x | x | ||||||
Noura et al. (2012) | x | x |